However, ascribing the reported effects of Gal-3 in infections to its binding to CD13 on myeloid cells is difficult, because potential saccharide ligands for Gal-3 are present on various different glycoproteins on the membrane of these cells. This evidence concerns the gene LGALS3 and infection.